Autolus Therapeutics plc
Autolus Therapeutics develops engineered T cell therapies for cancer and autoimmune diseases using proprietary programming technologies.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 10Latest story
Autolus Therapeutics develops engineered T cell therapies for cancer and autoimmune diseases using proprietary programming technologies.
November 2026
August 2026